Sign In
Buy ARKG
$33.15
-0.260 (-0.778%)
At Close: Jun 08, 2026
Biotech Tops in November: Best ETFs & Stocks
05:15pm, Friday, 29'th Nov 2019
The biotech space of the broad healthcare sector outperformed others in November, courtesy of a series of positive news including study results, regulatory backdrop and deal activities.
The Zacks Analyst Blog Highlights: GLD, CRSP, GBT, ALNY and ARKG
04:30pm, Friday, 29'th Nov 2019
The Zacks Analyst Blog Highlights: GLD, CRSP, GBT, ALNY and ARKG
Why Gold is Headed to Zero -- And What You Should Buy Instead
10:33pm, Wednesday, 27'th Nov 2019
Why Gold is Headed to Zero -- And What You Should Buy Instead
Why Gold is Headed to Zero -- And What You Should Buy Instead
12:00am, Wednesday, 27'th Nov 2019Genomics ETFs Surge on CRISPR's Gene Editing Progress
11:55pm, Monday, 25'th Nov 2019
The release of encouraging data on the CRISPR/Cas9 gene-editing therapy CTX001 for two severe blood disorders puts emphasis on some genomic ETFs.
ARK Invest ETFs Focus on Disruptive Companies
10:49pm, Monday, 18'th Nov 2019
For anyone not familiar with ARK Invest, they have a suite of ETF strategies dedicated to helping investors hone in on disruptive innovations and technologies with the potential to affect the global e
ARK Invest ETFs Track Disruptive Companies Changing the World
10:45pm, Monday, 18'th Nov 2019
For anyone not familiar with ARK Invest, they have a suite of ETF strategies dedicated to helping investors hone in on disruptive innovations and technologies with the potential to affect the global e
An Active ETF Approach to Target Innovations in Next Generation Sequencing
09:06pm, Thursday, 14'th Nov 2019
There are new developments in DNA sequencing that are making a huge impact on healthcare and the direction of growth in the industry. To take advantage of this opportunity, investors can look to a ta
Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks
06:31pm, Thursday, 14'th Nov 2019
Decent fundamentals and valuations as well as encouraging developments put these medical ETFs and stocks in focus.
